GE brings $3B life sciences project to light

General Electric has pumped $700 million into its ambitious healthcare R&D program, an effort that spans everything from new ventures in genetic testing to advances on life sciences projects and medical technology. In an annual review of its work in the field, GE also highlighted the launch of its $250 million equity fund, which is in the hunt for new technology. "In terms of cost, quality and access, we're really on track," GE's Mike Barber tells Bloomberg. GE plans to invest a total of $3...